Results 161 to 170 of about 26,235 (263)
Late Complications After Aortic Coarctation Repair. [PDF]
Santoro A +4 more
europepmc +1 more source
Fetal Ductal Constriction, Pulmonary Hypertension and Atrial Septum Mobility
Objectives Fetuses with ductal constriction (FDC), pulmonary hypertension and right ventricular overload after maternal exposure to PGE2 inhibitors—nonsteroidal anti‐inflammatory drugs (NSAIDs) or polyphenols (PF)—have increased septum primum excursion index (SPEI), the ratio between maximal septum primum displacement and left atrial diameter.
Paulo Zielinsky +5 more
wiley +1 more source
Multimodality Imaging Approach in Diagnosis and Follow-Up of Aortic Coarctation in Adulthood. [PDF]
La Mura L +8 more
europepmc +1 more source
American Journal of Medical Genetics Part A, Volume 200, Issue 6, Page 1427-1430, June 2026.
Alberto De Rosa +7 more
wiley +1 more source
Graphical summary of a longitudinal multiparametric MRI study in mouse TAC model, showing imaging at baseline, 3 days, 4 weeks and 7 weeks. All TAC animals developed global LV hypertrophy (+62% LV mass at week 7), but half displayed a spared‐hypertrophy basolateral region.
Vitali Koch +6 more
wiley +1 more source
Aortic Valve Stenosis and Insufficiency Combined With Aortic Coarctation. [PDF]
Hu T, Tu W, Li L.
europepmc +1 more source
Amentoflavone, a preferentially TGF‐ββ receptor 1 inhibitor, attenuates transverse aortic constriction (TAC)‐triggered cardiac hypertrophy, fibrosis, and dysfunction by suppressing downstream Smad and MAPK signaling cascades in cardiomyocytes and cardiac fibroblasts.
Jiangjiao Wu +10 more
wiley +1 more source
Noninvasive hemodynamic assessment of aortic coarctation: multimodal imaging based-computational fluid dynamics. [PDF]
Hu M +8 more
europepmc +1 more source
Hederagenin Attenuates Cardiac Remodeling by Targeting Phosphodiesterase 9A
ABSTRACT Background and Aim New therapeutic strategies for heart failure are urgently needed. The protective effects of cyclic guanosine monophosphate (cGMP)—protein kinase G (PKG) pathway on heart have been widely reported. Despite phosphodiesterase 9A (PDE9A) inhibitors combating cardiac remodeling, clinically available drugs are lacking. Hederagenin
Liqian Chen +16 more
wiley +1 more source
Aortic Coarctation Progresses to Become Functional Interrupted Aortic Arch. [PDF]
Wang L +8 more
europepmc +1 more source

